Frailty Clinical Trial - Effects of Low-dose Esmolol on Myocardial Injury

Status Recruiting

Clinical Trial Summary

This topic will focus on the following questions: 1. Part one: To clarify the relationship between preoperative frailty and myocardial injury (cTnT ≥0.03) after non-cardiac surgery in elderly patients; To further explore the predictive factors of myocardial injury after non-cardiac surgery （MINS） in elderly frail patients before operation. 2. Part Two: To explore the effect of low-dose esmolol on myocardial injury after non-cardiac surgery in frail elderly patients.

Clinical Trial Description

Esmol is a short-acting selective β-adrenergic receptor blocker, which is often used in patients with cardiovascular diseases or hypertension. It is also used to reduce stress response, control heart rate and reduce myocardial oxygen consumption during perioperative period to effectively protect cardiac function. However, the safety and efficacy of perioperative β-blockers are still controversial due to their possible effects on renal function. Several recent studies have shown that β-blockers reduce perioperative myocardial ischemia and may reduce the risk of perioperative myocardial infarction (PMI) and cardiovascular death in high-risk patients . The 2021 American College of Cardiology /American Heart Association (ACC/AHA )guidelines for coronary revascularization suggest that dose adjustment can optimize the clinical effects of β-blockers, thereby reducing adverse effects during treatment . In addition, several studies have found that continuous intraoperative infusion of low-dose esmolol (5-10μg/kg/min) can reduce intraoperative stress response and maintain hemodynamic stability. The meta-analysis of esmolol by Ollila A et al. found that esmolol has a promising application in the prevention of perioperative myocardial ischemia and serious complications associated with long-term ischemia. Does perioperative Esmolol reduce the incidence of myocardial injury after non-cardiac surgery （MINS）? The safety, outcome and benefit of perioperative esmolol in frail patients are still unclear. Therefore, this study intends to apply the appropriate dose of esmolol to prevent cardiovascular events in elderly frailty patients undergoing non-cardiac surgery, and explore the effect of low-dose esmolol on MINS in elderly frail patients, so as to provide feasible clinical measures for the safe outcome and rehabilitation of frail patients during perioperative period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05635877
Study type	Interventional
Source	Qianfoshan Hospital
Contact	yongtao Sun, PH.D
Phone	18660795201
Email	sunyongtao1979@163.com
Status	Recruiting
Phase	Phase 4
Start date	February 7, 2023
Completion date	December 30, 2026

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04992286` - Detection, Evaluation and Monitoring of Frailties in the Elderly (FRAGING)	N/A
Enrolling by invitation	`NCT05009706` - Self-care in Older Frail Persons With Heart Failure Intervention	N/A
Recruiting	`NCT05529147` - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting	`NCT04444544` - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed	`NCT04061785` - Impact of Skills Acquired Through Judo Training on Risk Factors for Falling in Elderly Men and Women	N/A
Completed	`NCT04140890` - Supporting Habit Formation to Attenuate Prefrailty in Elders: Pilot Study	N/A
Recruiting	`NCT03141866` - Seated Physical Activity in Ageing	N/A
Completed	`NCT04888884` - Loss of Independence - a Rapid Alternative to Frailty Screening in a Swedish ED Setting
Recruiting	`NCT04145726` - Frailty In Thoracic Surgery for Esophageal Cancer
Recruiting	`NCT04717869` - Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
Not yet recruiting	`NCT06022666` - PATH Program for for Severely Frail or Cognitively Impaired Patients Scheduled for Cancer Surgery.	N/A
Not yet recruiting	`NCT04514536` - Evaluation of a Health Monitoring Platform for Elderly in Home Care Context	N/A
Completed	`NCT01126723` - Effects of Tai Chi on Frailty in Elderly Adults	N/A
Completed	`NCT00183040` - HORMA: Hormonal Regulators of Muscle and Metabolism in Aging	Phase 2
Active, not recruiting	`NCT05961319` - Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults
Enrolling by invitation	`NCT05047731` - Antihypertensive Deprescribing in Long-term Care	N/A
Completed	`NCT04956705` - Vitamin D and Calcium Supplementation at Danish Nursing Homes	N/A
Recruiting	`NCT03824106` - Frailty Rehabilitation	Phase 4
Recruiting	`NCT04518423` - Prevalence, Determinants and Natural History of Frailty and Pre-frailty in Elderly People
Completed	`NCT04087343` - Strength on Wheels: A Meal Delivery and Exercise Intervention for Homebound Older Adults	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms